Vittorio Bolcato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vittorio Bolcato has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Giuseppe Basile
Department of Biomedical Sciences and Public Health, University “Politecnica delle Marche” of Ancona, 60124 Ancona, Italy
19 shared publications - Livio Pietro Tronconi
Department of Health and Life Science, European University of Rome, 00163 Rome, Italy
18 shared publications - Luca Bianco Prevot
IRCCS Istituto Ortopedico Galeazzi-Sant’Ambrogio, Via Cristina Belgioioso 173, 20157 Milan, Italy
11 shared publications - Valeria Brazzelli
Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
7 shared publications Livio Pietro Tronconi
6 shared publicationsGiuseppe Basile
5 shared publications
Latest Publications
- Open Access
Transcatheter Aortic Valve Implantation in Centers Without Cardiac Surgery: A Preliminary Medico-Legal Discussion in Italy
Background/Objectives: The expansion of minimally invasive and transcatheter approaches has progressively blurred boundaries between medical and surgical disciplines. Valvular heart diseases, especially aortic ones, exemplify this translational shift, with transcatheter aortic valve implantation (TAVI) increasingly replacing conventional cardiac surgery. Current guidelines recommend the performance of these procedures in centers equipped with on-site cardiac surgery, ensuring management of time-dependent complications. In fact, even if the incidence of major complications is low, the absence of immediate surgical bailout may translate into a concrete loss of therapeutic opportunity. Methods: The authors discuss the forensic implications of performing TAVI in centers without on-site cardiac surgery. Results: Patient safety is an integral component of the right to health, emphasizing risks minimization. Structural or logistical inability to manage foreseeable complications, or safety mechanisms constraint in elective treatments may therefore constitute a harm of this right. In this context, several aspects must be considered in light of guideline evidence and available data, including the training and competencies of medical and surgical specialties in Italy; the lack of data on the timing of complication management and related mortality, with the consequent hypothesis of therapeutic delay; and the liability of Heart Team members in cases of deviation from the guidelines. Moreover, the issue of proximity of care and the Heart Valve Center model and the adequacy of patient information must be considered. Conclusion: Overall, while TAVI represents a major advance, it must be supported by organizational models proportionate to its complexity, integrating patient safety, healthcare accountability, and patient’s right to health.
Open AccessTranscatheter Aortic Valve Implantation in Centers Without Cardiac Surgery: A Preliminary Medico-Legal Discussion in Italy
Background/Objectives: The expansion of minimally invasive and transcatheter approaches has progressively blurred boundaries between medical and surgical disciplines. Valvular heart diseases, especially aortic ones, exemplify this translational shift, with transcatheter aortic valve implantation (TAVI) increasingly replacing conventional cardiac surgery. Current guidelines recommend the performance of these procedures in centers equipped with on-site cardiac surgery, ensuring management of time-dependent complications. In fact, even if the incidence of major complications is low, the absence of immediate surgical bailout may translate into a concrete loss of therapeutic opportunity. Methods: The authors discuss the forensic implications of performing TAVI in centers without on-site cardiac surgery. Results: Patient safety is an integral component of the right to health, emphasizing risks minimization. Structural or logistical inability to manage foreseeable complications, or safety mechanisms constraint in elective treatments may therefore constitute a harm of this right. In this context, several aspects must be considered in light of guideline evidence and available data, including the training and competencies of medical and surgical specialties in Italy; the lack of data on the timing of complication management and related mortality, with the consequent hypothesis of therapeutic delay; and the liability of Heart Team members in cases of deviation from the guidelines. Moreover, the issue of proximity of care and the Heart Valve Center model and the adequacy of patient information must be considered. Conclusion: Overall, while TAVI represents a major advance, it must be supported by organizational models proportionate to its complexity, integrating patient safety, healthcare accountability, and patient’s right to health.
- Open Access
- 7 May 2026
- Published by MDPI AG in Preprints.org
Economic Analysis of Hospital Acquired Infections in a Cardiac Surgery Center: Impact on Healthcare Financing, Planning, and Risk Management
Background: Hospital-acquired infections (HAIs) represent a major source of morbidity, mortality, and increasing healthcare costs. In Europe, their impact stays significant, especially in high-risk settings such as cardiovascular surgery. Despite this, the economic burden of HAIs is still insufficiently characterized. Objective: This retrospective study aims to analyze HAIs’ costs in an Italian private cardiac surgery hospital between 2022 and 2024. Methods: Starting from the HAI reports of the Infection Prevention and Control (IPC) Committee, individual events were extracted and matched with costs obtained from the business management control system. The same process was applied to matched non-infected cases. A pseudonymized database was later created for analysis. Costs were assessed using a bottom-up approach and evaluated against reimbursements based on the Diagnosis Related Group (DRG) system, which provides standardized tariffs for acute hospital care. Results: With a mean HAI incidence of 7.3% and a prevalence of bloodstream ones, HAI patients had statistically significantly longer hospital stays, averaging 23.5 days compared to 10 days in non-HAI patients (p < 0.001). Economically, HAIs imposed a substantial burden. The average cost per infected patient was approximately 41.000€, nearly double the DRG reimbursement, resulting in a mean pecuniary loss of about 18.600€ per case. The incremental cost attributable to HAIs vs non-HAIs was 19.700€ per patient (p < 0.001), largely driven by ICU-related expenses (53%). Conclusion: These findings highlight a partial mismatch between resource consumption and DRG-based reimbursement in complex, high-intensity care, such as cardiac surgery and a significant economic burden of HAIs. Strengthening IPC strategies is essential to improve outcomes and resource allocation.
- 7 May 2026
- Published by MDPI AG in Preprints.org
Open AccessEconomic Analysis of Hospital Acquired Infections in a Cardiac Surgery Center: Impact on Healthcare Financing, Planning, and Risk Management
Background: Hospital-acquired infections (HAIs) represent a major source of morbidity, mortality, and increasing healthcare costs. In Europe, their impact stays significant, especially in high-risk settings such as cardiovascular surgery. Despite this, the economic burden of HAIs is still insufficiently characterized. Objective: This retrospective study aims to analyze HAIs’ costs in an Italian private cardiac surgery hospital between 2022 and 2024. Methods: Starting from the HAI reports of the Infection Prevention and Control (IPC) Committee, individual events were extracted and matched with costs obtained from the business management control system. The same process was applied to matched non-infected cases. A pseudonymized database was later created for analysis. Costs were assessed using a bottom-up approach and evaluated against reimbursements based on the Diagnosis Related Group (DRG) system, which provides standardized tariffs for acute hospital care. Results: With a mean HAI incidence of 7.3% and a prevalence of bloodstream ones, HAI patients had statistically significantly longer hospital stays, averaging 23.5 days compared to 10 days in non-HAI patients (p < 0.001). Economically, HAIs imposed a substantial burden. The average cost per infected patient was approximately 41.000€, nearly double the DRG reimbursement, resulting in a mean pecuniary loss of about 18.600€ per case. The incremental cost attributable to HAIs vs non-HAIs was 19.700€ per patient (p < 0.001), largely driven by ICU-related expenses (53%). Conclusion: These findings highlight a partial mismatch between resource consumption and DRG-based reimbursement in complex, high-intensity care, such as cardiac surgery and a significant economic burden of HAIs. Strengthening IPC strategies is essential to improve outcomes and resource allocation.
- Open Access
- 30 March 2026
- Published by Springer Nature in Emergency Radiology
- Vol. 33 (3) , 561-570
Occult fractures in low-energy trauma—A retrospective forensic case series
Background: Occult fractures (OFs) are inapparent fractures on initial plain radiographs, retrospectively diagnosed through second level imaging. The reasons for further diagnostic investigation may be the persistence of symptoms, or various personal needs, including insurance related. OFs, typically associated with low-energy trauma, are often underdiagnosed in the acute phase; however, they are relevant in the medico-legal field, as failure to identify them or delays in diagnosis and treatment may determine disability and give rise to complaint. Authors aim to describe OFs observed in a forensic case series. Methods: A retrospective study was conducted on technical expert consultations carried out between 2018 and 2024. Patients who sustained low-energy trauma with no evidence of fracture on plain radiography, followed by a later diagnosis of OF, were enrolled. Informed consent was signed. In each case, demographic data, trauma characteristics, diagnostic timelines, fracture locations, and details of any compensation claims were collected. Results: 312 cases of OFs were included, with a prevalence at the sacrum (29.5%), posterior pelvic ring (18.8%), carpal scaphoid (16.0%). In 68.5% of cases, the diagnostic delay exceeded 15 days. More than two thirds of the anatomical sites involved by OFs typically require conservative therapeutical management. In 41.3% of occult fracture cases, a claim for alleged malpractice compensation was filed, in 23.7% claiming an increased damage due to diagnostic–therapeutic delay. Failure to recommend clinical–radiological follow-up, as well as inadequate documentation of signs and symptoms and of trauma dynamics, were also found. Conclusions: Occult fractures represent a critical issue in medico-legal practice as the increasing time from trauma to diagnosis may lead to litigation. The adoption of diagnostic protocols for low-energy trauma in selected settings that account for the risk of occult fractures, together with enhanced clinical assessment and documentation, is essential to prevent complaints.
- 30 March 2026
- Published by Springer Nature in Emergency Radiology
- Vol. 33 (3) , 561-570
Open AccessOccult fractures in low-energy trauma—A retrospective forensic case series
Background: Occult fractures (OFs) are inapparent fractures on initial plain radiographs, retrospectively diagnosed through second level imaging. The reasons for further diagnostic investigation may be the persistence of symptoms, or various personal needs, including insurance related. OFs, typically associated with low-energy trauma, are often underdiagnosed in the acute phase; however, they are relevant in the medico-legal field, as failure to identify them or delays in diagnosis and treatment may determine disability and give rise to complaint. Authors aim to describe OFs observed in a forensic case series. Methods: A retrospective study was conducted on technical expert consultations carried out between 2018 and 2024. Patients who sustained low-energy trauma with no evidence of fracture on plain radiography, followed by a later diagnosis of OF, were enrolled. Informed consent was signed. In each case, demographic data, trauma characteristics, diagnostic timelines, fracture locations, and details of any compensation claims were collected. Results: 312 cases of OFs were included, with a prevalence at the sacrum (29.5%), posterior pelvic ring (18.8%), carpal scaphoid (16.0%). In 68.5% of cases, the diagnostic delay exceeded 15 days. More than two thirds of the anatomical sites involved by OFs typically require conservative therapeutical management. In 41.3% of occult fracture cases, a claim for alleged malpractice compensation was filed, in 23.7% claiming an increased damage due to diagnostic–therapeutic delay. Failure to recommend clinical–radiological follow-up, as well as inadequate documentation of signs and symptoms and of trauma dynamics, were also found. Conclusions: Occult fractures represent a critical issue in medico-legal practice as the increasing time from trauma to diagnosis may lead to litigation. The adoption of diagnostic protocols for low-energy trauma in selected settings that account for the risk of occult fractures, together with enhanced clinical assessment and documentation, is essential to prevent complaints.
- Open Access
- 15 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (2) , 227
When Intuition Meets the Algorithm: Medico-Legal Implications of Artificial Intelligence-Driven Decision-Making in Orthopedics
Orthopedic surgery is undergoing a transformation driven by artificial intelligence (AI), which is reshaping clinico-surgical decision-making. While the operative strategy and professional responsibility traditionally relied on the surgeon’s intuition and manual skills, advanced algorithms now provide predictive, analytical, and procedural decision supports. This paradigm shift is redefining the concept of human error as well as the relationship between technological tools and human decision-makers. As a result, the foundational elements of the healthcare liability framework are being affected. This paper offers a narrative discussion on selected applications of artificial intelligence in orthopedic surgical practice, including patient risk stratification, surgical indication and prosthesis positioning, with a particular focus on the liability implications for healthcare professionals who rely on these systems in terms of therapeutic decision-making. The aim is then to provide a comprehensive medico-legal perspective within the highly regulated and high-risk field of biomedicine, acknowledging and critically assessing the roles and responsibilities of all stakeholders involved—patients, healthcare professionals, innovative technologies, healthcare organizations, and facility management—while balancing innovation, evidence-based practice, and accountability in healthcare delivery.
- 15 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (2) , 227
Open AccessWhen Intuition Meets the Algorithm: Medico-Legal Implications of Artificial Intelligence-Driven Decision-Making in Orthopedics
Orthopedic surgery is undergoing a transformation driven by artificial intelligence (AI), which is reshaping clinico-surgical decision-making. While the operative strategy and professional responsibility traditionally relied on the surgeon’s intuition and manual skills, advanced algorithms now provide predictive, analytical, and procedural decision supports. This paradigm shift is redefining the concept of human error as well as the relationship between technological tools and human decision-makers. As a result, the foundational elements of the healthcare liability framework are being affected. This paper offers a narrative discussion on selected applications of artificial intelligence in orthopedic surgical practice, including patient risk stratification, surgical indication and prosthesis positioning, with a particular focus on the liability implications for healthcare professionals who rely on these systems in terms of therapeutic decision-making. The aim is then to provide a comprehensive medico-legal perspective within the highly regulated and high-risk field of biomedicine, acknowledging and critically assessing the roles and responsibilities of all stakeholders involved—patients, healthcare professionals, innovative technologies, healthcare organizations, and facility management—while balancing innovation, evidence-based practice, and accountability in healthcare delivery.
- Open Access
- 11 December 2025
- Published by MDPI AG in Nursing Reports
- Vol. 15 (12) , 443
Nursing Assistant in Italy: The Principle of Delegation of Health Activities and Liability Profiles
Background/Objectives: The institution of the nursing assistant (NA) profile in Italy, established by the Decree 28 February 2025 responds to the chronic shortage of healthcare personnel, especially in nursing. This figure, non-healthcare but trained to perform basic healthcare tasks, aims to support nurses and ensure continuity of care, especially in community and long-term care settings, through further nursing activities delegation. The model aligns with international practices, emphasizing delegation within multiprofessional teams, based on formalized protocols and continuous on-site training, within standardized, low-discretion contexts. The delegation of health activities, however, presents legal and medico-legal challenges regarding scope of practice and supervision. Methods: The aim of this paper is critically discussing delegation of health activities to non-healthcare providers and the related issues of liability in team-based delivery of care, considering the specific regulatory setting of health providers in Italy. Results: Critical activities such as nutrition and hydration, in particular artificially, and drug administration highlight the limits of delegation and the ongoing need for professional nurse oversight. In pre-hospital emergency care, standardized, protocol-based systems and simulation-based training successfully integrate non-healthcare personnel within the health team. Conversely, chronic and long-term care remain fragmented, lacking organizational maturity, regular supervision, and uniform regulation. Conclusions: The decree represents a step toward structured team-based care, but its success depends on robust governance, protocol clarity, organizational guidelines, and sustained practice-based education to prevent unsafe delegation and unauthorized practice.
- 11 December 2025
- Published by MDPI AG in Nursing Reports
- Vol. 15 (12) , 443
Open AccessNursing Assistant in Italy: The Principle of Delegation of Health Activities and Liability Profiles
Background/Objectives: The institution of the nursing assistant (NA) profile in Italy, established by the Decree 28 February 2025 responds to the chronic shortage of healthcare personnel, especially in nursing. This figure, non-healthcare but trained to perform basic healthcare tasks, aims to support nurses and ensure continuity of care, especially in community and long-term care settings, through further nursing activities delegation. The model aligns with international practices, emphasizing delegation within multiprofessional teams, based on formalized protocols and continuous on-site training, within standardized, low-discretion contexts. The delegation of health activities, however, presents legal and medico-legal challenges regarding scope of practice and supervision. Methods: The aim of this paper is critically discussing delegation of health activities to non-healthcare providers and the related issues of liability in team-based delivery of care, considering the specific regulatory setting of health providers in Italy. Results: Critical activities such as nutrition and hydration, in particular artificially, and drug administration highlight the limits of delegation and the ongoing need for professional nurse oversight. In pre-hospital emergency care, standardized, protocol-based systems and simulation-based training successfully integrate non-healthcare personnel within the health team. Conversely, chronic and long-term care remain fragmented, lacking organizational maturity, regular supervision, and uniform regulation. Conclusions: The decree represents a step toward structured team-based care, but its success depends on robust governance, protocol clarity, organizational guidelines, and sustained practice-based education to prevent unsafe delegation and unauthorized practice.
- Open Access
- 10 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2600123
Nerve injury after total hip arthroplasty: etiology, preventive strategies and medico-legal considerations
Nerve injuries in total hip arthroplasty (THA) are rare but clinically and medico-legally significant adverse events, sometimes severely affecting patients' wellbeing through motor dysfunction and often permanent sensory alterations. Nerve injuries can result from complex interactions between a patient's pathophysiology, the technical aspects of surgery and individual response to surgical trauma - often rendering them not entirely avoidable. Professional liability should be assessed within a comprehensive framework, considering biological and procedural variables, adherence to clinical preventive measures, and proper documentation. This study provides a narrative review of the etiology of nerve injuries and identifies the nerves most frequently affected, with a focus on perioperative actions associated with specific nerve involvement. It also explores the medico-legal implications of post-THA nerve injuries, for an integrated approach to surgical risk management. Nerves more frequently involved during the four phases of the surgical management (preoperative, intraoperative, immediate postoperative and long-term postoperative) are, in order, the sciatic, the femoral, the obturator, the superior gluteal and the lateral femoral cutaneous nerves. Main activities and/or situations associated with the risk of nerve injury, to be prevented or managed properly, are the type of approach, specific intraoperative positioning and timing, surgical technique with ligations, dissections and retractors roles, limb length, local retraction or expansion due to infection, hematoma or cement loss. Therefore, the adverse outcomes should not be automatically interpreted as surgical negligence, especially when standard care and clinical risk management protocols have been followed and documented in clinical records. Thus, distinguishing between unfaulty adverse event and negligence. The definition of a risk prevention and management strategy for nerve injury represents the first step in patient safety and, consequently, in reducing the likelihood of professional liability claim following THA.
- 10 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2600123
Open AccessNerve injury after total hip arthroplasty: etiology, preventive strategies and medico-legal considerations
Nerve injuries in total hip arthroplasty (THA) are rare but clinically and medico-legally significant adverse events, sometimes severely affecting patients' wellbeing through motor dysfunction and often permanent sensory alterations. Nerve injuries can result from complex interactions between a patient's pathophysiology, the technical aspects of surgery and individual response to surgical trauma - often rendering them not entirely avoidable. Professional liability should be assessed within a comprehensive framework, considering biological and procedural variables, adherence to clinical preventive measures, and proper documentation. This study provides a narrative review of the etiology of nerve injuries and identifies the nerves most frequently affected, with a focus on perioperative actions associated with specific nerve involvement. It also explores the medico-legal implications of post-THA nerve injuries, for an integrated approach to surgical risk management. Nerves more frequently involved during the four phases of the surgical management (preoperative, intraoperative, immediate postoperative and long-term postoperative) are, in order, the sciatic, the femoral, the obturator, the superior gluteal and the lateral femoral cutaneous nerves. Main activities and/or situations associated with the risk of nerve injury, to be prevented or managed properly, are the type of approach, specific intraoperative positioning and timing, surgical technique with ligations, dissections and retractors roles, limb length, local retraction or expansion due to infection, hematoma or cement loss. Therefore, the adverse outcomes should not be automatically interpreted as surgical negligence, especially when standard care and clinical risk management protocols have been followed and documented in clinical records. Thus, distinguishing between unfaulty adverse event and negligence. The definition of a risk prevention and management strategy for nerve injury represents the first step in patient safety and, consequently, in reducing the likelihood of professional liability claim following THA.
- Open Access
Medico-Legal Considerations on the Clinico-Instrumental Correlation and the Role of Expertise in the Dermatological Diagnostic Pathway
Italian Court of Cassation Ruling Decree 30032 of 30 October 2023 discusses a medical malpractice case concerning the diagnosis of dermatofibrosarcoma protuberans and the alleged diagnostic and therapeutic delay. By examining how the ruling frames the role of histopathology in proving pathology benignity, authors prompt to reflect on diagnostic path, the allocation of the burden of proof, and the role of dermatologist’s expertise in professional liability issues. Over a four-year period, five health professionals were involved in a claim concerning an initial diagnosis of an epidermoid cyst and a subsequent diagnosis of dermatofibrosarcoma protuberans. The plaintiff questioned the delay in diagnosis, and the Court of Cassation found two physicians liable because they could not prove that the treated pathology was initially benign. We argue that equating diagnostic correctness exclusively with histological confirmation is unnecessary, both clinically and legally, in typical cases, if the reasoning and findings are adequately documented. Additionally, we examine the value of dermatologists’ experience and the scope of professional competence as measures of liability. Finally, we outline the minimum standards of clinical documentation necessary to make the diagnostic pathway traceable and verifiable. The diagnostic process is a discretionary effort that integrates multiple sources of information, both instrumental and experiential, to reach the most reasonable hypothesis. While histopathology is a crucial tool, it is not the sole gateway to a correct diagnosis of every cutaneous alteration. Adequate disclosure and structured documentation of the diagnostic reasoning are fundamental to the care process and fair assessment of professional responsibility.
Open AccessMedico-Legal Considerations on the Clinico-Instrumental Correlation and the Role of Expertise in the Dermatological Diagnostic Pathway
Italian Court of Cassation Ruling Decree 30032 of 30 October 2023 discusses a medical malpractice case concerning the diagnosis of dermatofibrosarcoma protuberans and the alleged diagnostic and therapeutic delay. By examining how the ruling frames the role of histopathology in proving pathology benignity, authors prompt to reflect on diagnostic path, the allocation of the burden of proof, and the role of dermatologist’s expertise in professional liability issues. Over a four-year period, five health professionals were involved in a claim concerning an initial diagnosis of an epidermoid cyst and a subsequent diagnosis of dermatofibrosarcoma protuberans. The plaintiff questioned the delay in diagnosis, and the Court of Cassation found two physicians liable because they could not prove that the treated pathology was initially benign. We argue that equating diagnostic correctness exclusively with histological confirmation is unnecessary, both clinically and legally, in typical cases, if the reasoning and findings are adequately documented. Additionally, we examine the value of dermatologists’ experience and the scope of professional competence as measures of liability. Finally, we outline the minimum standards of clinical documentation necessary to make the diagnostic pathway traceable and verifiable. The diagnostic process is a discretionary effort that integrates multiple sources of information, both instrumental and experiential, to reach the most reasonable hypothesis. While histopathology is a crucial tool, it is not the sole gateway to a correct diagnosis of every cutaneous alteration. Adequate disclosure and structured documentation of the diagnostic reasoning are fundamental to the care process and fair assessment of professional responsibility.
- Open Access
- 7 October 2025
- Published by MDPI AG in Medical Sciences
- Vol. 13 (4) , 222
Decentralized Clinical Trials: Governance, Ethics and Medico-Legal Issues for the New Paradigm of Research with a Focus on Cardiovascular Field
The evolution of decentralized clinical trials, driven by advanced digital technologies, is transforming traditional clinical research. It introduces innovative methods for informed consent, remote patient monitoring, and data analysis, enhancing study efficiency, validity, and participation while reducing patient burden. Some clinical procedures can be conducted remotely, increasing trial accessibility and reducing population selection biases, particularly for cardiovascular patients. However, this also presents complex regulatory and ethical challenges. The article explores how digital platforms and emerging technologies like block chain, AI, and advanced cryptography can promote traceability, security, and transparency throughout the trial process, ensuring participant identification and documentation of each procedural step. Clear, legally compliant informed consent, often managed through electronic systems, both for research participation and data management in line with GDPR, is essential. Ethical considerations include ensuring participants understand trial information, with adaptations such as simplified language, visual aids, and multilingual support. The transnational nature of decentralized trials highlights the need for coordinated regulatory standards to overcome jurisdictional barriers and reinforce accountability. This framework promotes trust, shared responsibility, and the protection of participants rights while upholding high ethical standards in scientific research.
- 7 October 2025
- Published by MDPI AG in Medical Sciences
- Vol. 13 (4) , 222
Open AccessDecentralized Clinical Trials: Governance, Ethics and Medico-Legal Issues for the New Paradigm of Research with a Focus on Cardiovascular Field
The evolution of decentralized clinical trials, driven by advanced digital technologies, is transforming traditional clinical research. It introduces innovative methods for informed consent, remote patient monitoring, and data analysis, enhancing study efficiency, validity, and participation while reducing patient burden. Some clinical procedures can be conducted remotely, increasing trial accessibility and reducing population selection biases, particularly for cardiovascular patients. However, this also presents complex regulatory and ethical challenges. The article explores how digital platforms and emerging technologies like block chain, AI, and advanced cryptography can promote traceability, security, and transparency throughout the trial process, ensuring participant identification and documentation of each procedural step. Clear, legally compliant informed consent, often managed through electronic systems, both for research participation and data management in line with GDPR, is essential. Ethical considerations include ensuring participants understand trial information, with adaptations such as simplified language, visual aids, and multilingual support. The transnational nature of decentralized trials highlights the need for coordinated regulatory standards to overcome jurisdictional barriers and reinforce accountability. This framework promotes trust, shared responsibility, and the protection of participants rights while upholding high ethical standards in scientific research.
- Open Access
- 2 September 2025
- Published by MDPI AG in Forensic Sciences
- Vol. 5 (3) , 40
From Laws and Court Rulings to Daily Clinical Practice: The Role of Forensic Experts in Modelling Informed Consent Disclosure for Health Treatment
Informed consent is a fundamental component of both the right to health and self-determination. Its violation, which occurs when the acquisition process is absent or flawed, can also lead to legal proceedings for isolated harm, regardless of the simultaneous existence of those related to biological and psychological harm. Across Europe, this remains a legal and ethical cornerstone, increasingly important in the context of cross-border care and culturally diverse healthcare settings. Many countries have enacted specific laws to ensure patients receive adequate information, while courts continue to refine its interpretation—often highlighting the inadequacy of informed consent in daily clinical practice. In Italy, in particular, recent rulings underscore the need for clear, comprehensive, and properly documented consent formats for health treatments. This review synthesizes rulings, regulations, and the scientific literature to offer practical guidance for improving informed consent practices in Italy, valuing the role of forensic experts in the integration in healthcare settings of the different interests at stake. The aim is to support both legal compliance and the delivery of high-quality, patient-centred care. Courts and legislation in Italy demand clear and tailored informative disclosure for health treatments, with indications of the treatment and outcomes, to be in written form. Yet, foreseeable risks, more common complications, and alternative treatment options are often poorly communicated in practice—frequently forming the basis of claims for compensation. Integrating team-based consultations and multimedia tools can significantly enhance patient understanding and secure the informed consent process. Those key points are summarized in a brief table, ideally suggesting the minimal requirements for an informed consent form. Investing in standardizing informed consent protocols, and also fostering the sharing of best practices with forensic medicine experts, are crucial steps in ensuring shared decision-making in healthcare and trying to reduce legal disputes.
- 2 September 2025
- Published by MDPI AG in Forensic Sciences
- Vol. 5 (3) , 40
Open AccessFrom Laws and Court Rulings to Daily Clinical Practice: The Role of Forensic Experts in Modelling Informed Consent Disclosure for Health Treatment
Informed consent is a fundamental component of both the right to health and self-determination. Its violation, which occurs when the acquisition process is absent or flawed, can also lead to legal proceedings for isolated harm, regardless of the simultaneous existence of those related to biological and psychological harm. Across Europe, this remains a legal and ethical cornerstone, increasingly important in the context of cross-border care and culturally diverse healthcare settings. Many countries have enacted specific laws to ensure patients receive adequate information, while courts continue to refine its interpretation—often highlighting the inadequacy of informed consent in daily clinical practice. In Italy, in particular, recent rulings underscore the need for clear, comprehensive, and properly documented consent formats for health treatments. This review synthesizes rulings, regulations, and the scientific literature to offer practical guidance for improving informed consent practices in Italy, valuing the role of forensic experts in the integration in healthcare settings of the different interests at stake. The aim is to support both legal compliance and the delivery of high-quality, patient-centred care. Courts and legislation in Italy demand clear and tailored informative disclosure for health treatments, with indications of the treatment and outcomes, to be in written form. Yet, foreseeable risks, more common complications, and alternative treatment options are often poorly communicated in practice—frequently forming the basis of claims for compensation. Integrating team-based consultations and multimedia tools can significantly enhance patient understanding and secure the informed consent process. Those key points are summarized in a brief table, ideally suggesting the minimal requirements for an informed consent form. Investing in standardizing informed consent protocols, and also fostering the sharing of best practices with forensic medicine experts, are crucial steps in ensuring shared decision-making in healthcare and trying to reduce legal disputes.
- Open Access
- 25 June 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (7) , 118
First Case of Infective Endocarditis Caused by Vibrio metschnikovii: Clinico-Diagnostic Complexities and a Systematic Literature Review
Background: Non-cholera Vibrio species are rare waterborne pathogens that can cause severe infections. Among these, few cases of Vibrio metschnikovii infections have been reported, especially in the gastrointestinal tract, with no cardiac tissue involvement as a result. Following the PRISMA checklist, we conducted a literature review, and thirteen articles for twenty-two cases overall were included: seven cases of sepsis (in three cases, the echocardiographic results were negative), seven cases of pneumonia, two skin infections, eleven cases of diarrhoea, and a gastroenteritis outbreak. This report documents the expanding clinical spectrum and the role played by V. metschnikovii in infective endocarditis. Case report: A 28-year-old male patient was referred to the cardiac surgery unit for urgent mitral valve replacement due to suspicion of infective endocarditis. Microbiological tests yielded negative results. Following recovery and discharge with antimicrobial therapy for 6 weeks, the patient experienced prosthesis detachment, necessitating re-hospitalisation for an emergency valve replacement. Vibrio metschnikovii was identified on the prosthesis valve through PCR and successfully treated with ciprofloxacin. However, a spontaneous rupture of the ascending thoracic aorta led to a neurological injury. Discussion: This case represents the first case of valve infection caused by Vibrio metschnikovii, characterised by diagnostic and therapeutic challenges and the involvement of the great vessels. Also considered in this case, for a disease with a median age of 58 years (11–83) and a male-to-female ratio of 2.2, were one male neonate and six cases for whom neither sex nor age was indicated. Excluding gastrointestinal cases, the septic forms are associated with high morbidity, although the single case described involved a young and healthy subject. Risk factors for the pathogen or predisposing/pathological conditions for endocarditis did not emerge. The routes and the time of infection could not be determined, deepening the possibility of occupational exposure via the patient’s position as a boat worker. Poor sensitivity to third-generation cephalosporins has been reported in the literature: the absence of an antibiogram does not allow for a comparison, although resolution was achieved with ciprofloxacin. Conclusion: The rising global incidence of non-cholera Vibrio infections, driven by environmental changes, calls for urgent research into the factors behind their pathogenicity and infection routes. Diagnostic complexities have emerged together with clinical severity.
- 25 June 2025
- Published by MDPI AG in Clinics and Practice
- Vol. 15 (7) , 118
Open AccessFirst Case of Infective Endocarditis Caused by Vibrio metschnikovii: Clinico-Diagnostic Complexities and a Systematic Literature Review
Background: Non-cholera Vibrio species are rare waterborne pathogens that can cause severe infections. Among these, few cases of Vibrio metschnikovii infections have been reported, especially in the gastrointestinal tract, with no cardiac tissue involvement as a result. Following the PRISMA checklist, we conducted a literature review, and thirteen articles for twenty-two cases overall were included: seven cases of sepsis (in three cases, the echocardiographic results were negative), seven cases of pneumonia, two skin infections, eleven cases of diarrhoea, and a gastroenteritis outbreak. This report documents the expanding clinical spectrum and the role played by V. metschnikovii in infective endocarditis. Case report: A 28-year-old male patient was referred to the cardiac surgery unit for urgent mitral valve replacement due to suspicion of infective endocarditis. Microbiological tests yielded negative results. Following recovery and discharge with antimicrobial therapy for 6 weeks, the patient experienced prosthesis detachment, necessitating re-hospitalisation for an emergency valve replacement. Vibrio metschnikovii was identified on the prosthesis valve through PCR and successfully treated with ciprofloxacin. However, a spontaneous rupture of the ascending thoracic aorta led to a neurological injury. Discussion: This case represents the first case of valve infection caused by Vibrio metschnikovii, characterised by diagnostic and therapeutic challenges and the involvement of the great vessels. Also considered in this case, for a disease with a median age of 58 years (11–83) and a male-to-female ratio of 2.2, were one male neonate and six cases for whom neither sex nor age was indicated. Excluding gastrointestinal cases, the septic forms are associated with high morbidity, although the single case described involved a young and healthy subject. Risk factors for the pathogen or predisposing/pathological conditions for endocarditis did not emerge. The routes and the time of infection could not be determined, deepening the possibility of occupational exposure via the patient’s position as a boat worker. Poor sensitivity to third-generation cephalosporins has been reported in the literature: the absence of an antibiogram does not allow for a comparison, although resolution was achieved with ciprofloxacin. Conclusion: The rising global incidence of non-cholera Vibrio infections, driven by environmental changes, calls for urgent research into the factors behind their pathogenicity and infection routes. Diagnostic complexities have emerged together with clinical severity.